Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ; Uganda Cancer Institute, Makerere University College of Health Sciences, Kampala, Uganda ; School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Clin Epidemiol. 2012;4:339-47. doi: 10.2147/CLEP.S35671. Epub 2012 Dec 14.
Correct diagnosis is key to appropriate treatment of cancer in children. However, diagnostic challenges are common in low-income and middle-income countries. The objective of the present study was to assess the agreement between a clinical diagnosis of childhood non- Hodgkin lymphoma (NHL) assigned in Uganda, a pathological diagnosis assigned in Uganda, and a pathological diagnosis assigned in The Netherlands.
The study included children with suspected NHL referred to the Mulago National Referral Hospital, Kampala, Uganda, between 2004 and 2008. A clinical diagnosis was assigned at the Mulago National Referral Hospital, where tissue samples were also obtained. Hematoxylin and eosin-stained slides were used for histological diagnosis in Uganda, and were re-examined in a pathology laboratory in The Netherlands, where additional pathological, virological and serological testing was also carried out. Agreement between diagnostic sites was compared using kappa statistics.
Clinical and pathological diagnoses from Uganda and pathological diagnosis from The Netherlands was available for 118 children. The agreement between clinical and pathological diagnoses of NHL assigned in Uganda was 91% (95% confidence interval [CI] 84-95; kappa 0.84; P < 0.001) and in The Netherlands was 49% (95% CI 40-59; kappa 0.04; P = 0.612). When Burkitt's lymphoma was considered separately from other NHL, the agreement between clinical diagnoses in Uganda and pathological diagnoses in Uganda was 69% (95% CI 59-77; kappa 0.56; P < 0.0001), and the corresponding agreement between pathological diagnoses assigned in The Netherlands was 32% (95% CI 24-41; kappa 0.05; P = 0.326). The agreement between all pathological diagnoses assigned in Uganda and The Netherlands was 36% (95% CI 28-46; kappa 0.11; P = 0.046).
Clinical diagnosis of NHL in Uganda has a high probability of error compared with pathological diagnosis in Uganda and in The Netherlands. In addition, agreement on the pathological diagnosis of NHL between Uganda and The Netherlands is very low.
正确诊断是儿童癌症适当治疗的关键。然而,在低收入和中等收入国家,诊断挑战很常见。本研究的目的是评估在乌干达做出的儿童非霍奇金淋巴瘤(NHL)临床诊断、在乌干达做出的病理诊断和在荷兰做出的病理诊断之间的一致性。
本研究纳入了 2004 年至 2008 年间转诊至乌干达坎帕拉市穆拉戈国家转诊医院的疑似 NHL 患儿。在穆拉戈国家转诊医院做出临床诊断,同时获取组织样本。乌干达使用苏木精和伊红染色切片进行组织病理学诊断,在荷兰的一个病理实验室进行重新检查,同时还进行了额外的病理、病毒学和血清学检测。使用 Kappa 统计比较诊断地点之间的一致性。
118 名患儿的乌干达临床和病理诊断以及荷兰的病理诊断结果可用。在乌干达做出的 NHL 临床和病理诊断之间的一致性为 91%(95%置信区间 [CI] 84-95;Kappa 值 0.84;P < 0.001),在荷兰做出的 NHL 临床和病理诊断之间的一致性为 49%(95% CI 40-59;Kappa 值 0.04;P = 0.612)。当将伯基特淋巴瘤与其他 NHL 分开考虑时,在乌干达做出的临床诊断与在乌干达做出的病理诊断之间的一致性为 69%(95% CI 59-77;Kappa 值 0.56;P < 0.0001),在荷兰做出的病理诊断之间的一致性为 32%(95% CI 24-41;Kappa 值 0.05;P = 0.326)。在乌干达和荷兰做出的所有病理诊断之间的一致性为 36%(95% CI 28-46;Kappa 值 0.11;P = 0.046)。
与乌干达和荷兰的病理诊断相比,乌干达做出的 NHL 临床诊断更有可能出现错误。此外,乌干达和荷兰之间 NHL 的病理诊断一致性非常低。